SOMERSET, N.J., Jan. 24 /PRNewswire-FirstCall/ -- Ventiv Pharma Services, LLC, a division of Ventiv Health, Inc. , announced today that PROMOTECH, its division dedicated to supporting pharmaceutical clients with a variety of program management services, has launched a mail order pharmacy. Through this service, PROMOTECH now provides its clients the opportunity for direct-to-patient and physician fulfillment through mail order, patient assistance programs and web ordering capabilities.
PROMOTECH's recent expansion enables the management of this pharmacy program through warehousing, fulfillment and distribution services. Additional support includes patient advocacy, physician and consumer helplines. Staffed with PharmDs, the new facility utilizes QS/1 state-of-the-art pharmacy software designed to service daily order processing.
Terry Herring, President and COO, Ventiv Pharma Services, comments "PROMOTECH's new pharmacy capability greatly expands our portfolio of non-promotional support services and positions us favorably to better meet the current and future needs of our customers."
"The pharmacy, when combined with our state-of-the-art data management systems, call center facility features and other capabilities, provides a convenient one-source vendor option for our clients," adds Warren Merlino, Managing Director of PROMOTECH.
Bill Shearer, Managing Director of The Franklin Group, a division of Ventiv Health which manages patient assistance programs for a large number of pharmaceutical companies, stated, "We can now provide turnkey patient assistance programs with product distribution to either the patient's home or the practitioner's office based on product type or client preference. The launch of the mail order pharmacy critically enhances our service offering in patient assistance."
The Franklin Group, a leader in designing and administering patient assistant programs throughout the nation, has just been awarded a new patient assistance program which will be the first to utilize PROMOTECH's new mail order pharmacy.
About Ventiv Health
Ventiv Health, Inc. is the leading provider of late-stage clinical, sales, marketing and compliance solutions to pharmaceutical and biotech companies. Ventiv is a multi-disciplinary company with a singular focus on providing excellence in customized solutions across the full spectrum of services combining both integrated and independent programs. Ventiv's approximately 4,000 employees support over 75 client organizations, including the world's Top 20 pharmaceuticals companies as well as emerging and specialty biotech leaders. For more information on Ventiv Health, visit http://www.ventiv.com/ .
About PROMOTECH
PROMOTECH, a division of Ventiv Health, is a specialized marketing support group providing direct mail, database management, teleservices and eServices to companies in the biotechnology and pharmaceutical industry. A non-personal promotions provider, PROMOTECH offers over 62,000 square feet supporting a call center, administrative offices and a drug and literature warehouse that is environmentally controlled, FDA and DEA certified, and PDMA compliant. For more information on PROMOTECH, please visit http://www.promotechdirect.com/ .
About The Franklin Group
The Franklin Group, a division of Ventiv Health, enables pharmaceutical companies to optimize their performance while maintaining compliance in the areas of sample accountability, patient assistance programs, and OIG. The coupling of The Franklin Group's in-depth content expertise with innovative process design, results in customized solutions that allow clients to achieve their business goals within the current pharmaceutical regulatory environment. For more information about The Franklin Group, please visit http://www.franklinpharmaservices.com/ .
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause Ventiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by Ventiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
Ventiv Health, Inc.CONTACT: Corporate - John Emery, CFO, Ventiv Health, Inc.,+1-732-537-4804, investor@ventiv.com; or Investors - Felicia Vonella,fvonella@lazarpartners.com, or Media - Kellie Walsh, kwalsh@lazarpartners.com,both of Lazar Partners Ltd., +1-212-867-1762, for Ventiv Health, Inc.